Skip to content

Clinical trials

Acute Coronary Syndrome trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: Australia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20071
20083
20096
20105
20111
20121
20141
20154
20161
20181
20191
20201
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Sanofi3
AstraZeneca2
Bristol-Myers Squibb2
Janssen Research & Development, LLC2
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
Astellas Pharma Europe B.V.1
Baim Institute for Clinical Research1
Biotronik, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome34
Myocardial Infarction11
Cardiovascular Diseases7
Coronary Artery Disease7
Myocardial Ischemia5
Atherosclerosis4
Heart Diseases4
Non-ST Elevated Myocardial Infarction4
ST Elevation Myocardial Infarction4
Stroke4

Trials

Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.